Cargando…

Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma

Analysis of The Cancer Genome Atlas data revealed that alternative splicing (AS) events could serve as prognostic biomarkers in various cancer types. This study examined lung adenocarcinoma (LUAD) tissues for AS and assessed AS events as potential indicators of prognosis in our cohort. RNA sequencin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Ya-Sian, Tu, Siang-Jyun, Chiang, Hui-Shan, Yen, Ju-Chen, Lee, Ya-Ting, Fang, Hsin-Yuan, Chang, Jan-Gowth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693837/ https://www.ncbi.nlm.nih.gov/pubmed/33142748 http://dx.doi.org/10.3390/genes11111300

Ejemplares similares

The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer
por: Chang, Ya-Sian, et al.
Publicado: (2021)

Exploring RNA modifications, editing, and splicing changes in hyperuricemia and gout
por: Huang, Chung-Ming, et al.
Publicado: (2022)

4β-Hydroxywithanolide E Modulates Alternative Splicing of Apoptotic Genes in Human Hepatocellular Carcinoma Huh-7 Cells
por: Lee, Chien-Chin, et al.
Publicado: (2017)

Metatranscriptomic Analysis of Human Lung Metagenomes from Patients with Lung Cancer
por: Chang, Ya-Sian, et al.
Publicado: (2021)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
por: Zhu, Jiwen, et al.
Publicado: (2023)

Mutation profile of non-small cell lung cancer revealed by next generation sequencing
por: Chang, Ya-Sian, et al.
Publicado: (2021)

Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer
por: Zong, Zhen, et al.
Publicado: (2018)

Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach
por: Dessie, Eskezeia Yihunie, et al.
Publicado: (2021)

Small Molecule Amiloride Modulates Oncogenic RNA Alternative Splicing to Devitalize Human Cancer Cells
por: Chang, Jan-Gowth, et al.
Publicado: (2011)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Identification of prognostic alternative splicing signature in gastric cancer
por: Wang, Zhiwu, et al.
Publicado: (2022)

Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma
por: Sun, Jian-Rong, et al.
Publicado: (2020)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma
por: Shi, Yu, et al.
Publicado: (2018)

Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer
por: Liu, Mian, et al.
Publicado: (2021)

Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma
por: Huang, Runzhi, et al.
Publicado: (2021)

Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia
por: Jin, Peng, et al.
Publicado: (2020)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods
por: Cai, Qidong, et al.
Publicado: (2020)

Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer
por: Yu, Min, et al.
Publicado: (2019)

Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease
por: Chang, Wen-Hsin, et al.
Publicado: (2017)

Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer
por: Zhao, Jiyu, et al.
Publicado: (2020)

Single-cell RNA sequencing of immune cells in patients with acute gout
por: Chang, Jan-Gowth, et al.
Publicado: (2022)

Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
por: Ouyang, Dong, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Immunological significance of alternative splicing prognostic signatures for bladder cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Characterization of alternative splicing events and prognostic signatures in breast cancer
por: Han, Pihua, et al.
Publicado: (2021)

Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis
por: Yao, Jun, et al.
Publicado: (2021)

Dysregulation of Immune Cell Subpopulations in Atypical Hemolytic Uremic Syndrome
por: Chen, I-Ru, et al.
Publicado: (2023)

Comprehensive Analysis and Drug Modulation of Human Endogenous Retrovirus in Hepatocellular Carcinomas
por: Chang, Ya-Sian, et al.
Publicado: (2023)

Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Alternative splicing in human cancer cells is modulated by the amiloride derivative 3,5‐diamino‐6‐chloro‐N‐(N‐(2,6‐dichlorobenzoyl)carbamimidoyl)pyrazine‐2‐carboxide
por: Lee, Chien‐Chin, et al.
Publicado: (2019)

Characterization of the alternative splicing landscape in lung adenocarcinoma reveals novel prognosis signature associated with B cells
por: Shao, Ming-Ming, et al.
Publicado: (2023)

An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors
por: Wang, Yidi, et al.
Publicado: (2020)

Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dcp49pj34h1i22b04op4rp73ep